Halozyme Therapeutics
HALO
#2101
Rank
โ‚ฌ6.96 B
Marketcap
56,53ย โ‚ฌ
Share price
1.38%
Change (1 day)
48.25%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): โ‚ฌ0.51 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.01 Billion. , an increase over its 2023 earnings that were of โ‚ฌ0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.51 B59.94%
2023 โ‚ฌ0.32 B39.94%
2022 โ‚ฌ0.23 B0.16%
2021 โ‚ฌ0.23 B92.2%
2020 โ‚ฌ0.11 B-278.96%
2019 -โ‚ฌ66.98 Million-9.45%
2018 -โ‚ฌ73.97 Million-229.51%
2017 โ‚ฌ57.11 M-160.48%
2016 -โ‚ฌ94.43 Million216.03%
2015 -โ‚ฌ29.88 Million-52.86%
2014 -โ‚ฌ63.39 Million-18.09%
2013 -โ‚ฌ77.39 Million55.88%
2012 -โ‚ฌ49.65 Million169.94%
2011 -โ‚ฌ18.39 Million-63.44%
2010 -โ‚ฌ50.3 Million-7.19%
2009 -โ‚ฌ54.19 Million15.91%
2008 -โ‚ฌ46.76 Million83.89%
2007 -โ‚ฌ25.43 Million78.1%
2006 -โ‚ฌ14.28 Million16%
2005 -โ‚ฌ12.31 Million45.24%
2004 -โ‚ฌ8.48 Million682.42%
2003 -โ‚ฌ1.09 Million1659.12%
2002 -โ‚ฌ0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ23.2 M-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.75 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.15 B-70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.43 B 1,146.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.36 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ16.16 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA